Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000349888

Medchemexpress LLC SK-575 | 2523016-96-6 | 99.9% | 876.97 | 25 MG
SDP

Catalog No. 5000349888
Encompass_Preferred

SK-575 is a highly potent and specific proteolysis-targeting chimera (PROTAC) degrader of PARP1, with an IC50 of 2.30 nM. It potently inhibits the growth of cancer cells bearing BRCA1/2 mutations.

  • Potently inhibits the growth of cancer cells bearing BRCA1/2 mutations.
  • Shows good PARP1 degradation activity in cancer cell lines.
  • Effectively induces the formation of γH2AX in MDA-MB-436 and Capan-1 cells in a dose-dependent manner.
  • Significantly inhibits tumor growth in HR-deficient xenograft models.
  • Achieves sufficient plasma exposure and effectively induces PARP1 degradation in tumor tissue.
  • Well tolerated in animal models.

Catalog No. 50-003-49888 Supplier Medchemexpress LLC Supplier No. 25MGHY139156
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SK-575 is a highly potent and specific proteolysis-targeting chimera (PROTAC) degrader of PARP1, with an IC50 of 2.30 nM. It potently inhibits the growth of cancer cells bearing BRCA1/2 mutations.

  • Potently inhibits the growth of cancer cells bearing BRCA1/2 mutations.
  • Shows good PARP1 degradation activity in cancer cell lines.
  • Effectively induces the formation of γH2AX in MDA-MB-436 and Capan-1 cells in a dose-dependent manner.
  • Significantly inhibits tumor growth in HR-deficient xenograft models.
  • Achieves sufficient plasma exposure and effectively induces PARP1 degradation in tumor tissue.
  • Well tolerated in animal models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.